Patents by Inventor Linda C. Burkly

Linda C. Burkly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Common gamma chain monoclonal antibody blocking agents
    Patent number: 6323027
    Abstract: The invention relates to antibodies which specifically bind to the gc chain of cytokine receptors, as well as to cell lines which produce such antibodies, pharmaceutical compositions, and methods of treating immunological diseases by treating patients with such antibodies.
    Type: Grant
    Filed: November 10, 1998
    Date of Patent: November 27, 2001
    Assignee: Biogen, Inc.
    Inventors: Linda C. Burkly, Christopher D. Benjamin, Catherine Hession, Adrian Whitty
  • Treatment for inflammatory bowel disease with VLA-4 blockers
    Patent number: 5932214
    Abstract: A method for the treatment of inflammatory bowel disease (IBD) is disclosed. The method comprises administration of an antibody, polypeptide or other molecule recognizing VLA-4, a surface molecule expressed on most types of white blood cells and involved in leukocyte adhesion to endothelium and other tissus in the gut.
    Type: Grant
    Filed: October 15, 1997
    Date of Patent: August 3, 1999
    Assignee: Biogen, Inc.
    Inventors: Roy R. Lobb, Linda C. Burkly
  • Treatment for insulin dependent diabetes
    Patent number: 5888507
    Abstract: A method for the prevention of insulin dependent (type I) diabetes. The method comprises administration of an antibody, polypeptide or other molecule recognizing VLA-4.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: March 30, 1999
    Assignee: Biogen, Inc.
    Inventor: Linda C. Burkly
  • Anti-CD4 antibody homologs useful in prophylaxis and treatment of AIDS, ARC and HIV infection
    Patent number: 5871732
    Abstract: Anti-CD4 antibody homologs, DNA sequences and recombinant DNA molecules encoding them, prophylactic, immunotherapeutic and diagnostic compositions comprising those antibody homologs, and methods for preventing or treating diseases in mammals, including humans, caused by infective agents whose primary targets are CD4.sup.+ lymphocytes. Such diseases include acquired immune deficiency syndrome ("AIDS"), AIDS related complex, and human immunodeficiency virus infection.
    Type: Grant
    Filed: November 27, 1991
    Date of Patent: February 16, 1999
    Assignee: Biogen, Inc.
    Inventors: Linda C. Burkly, Patricia L. Chisholm, David W. Thomas, Margaret D. Rosa, Joseph J. Rosa
  • Treatment for asthma with VLA-4 blocking agents
    Patent number: 5871734
    Abstract: A method for the treatment of asthma is disclosed. The method comprises administration of an antibody, polypeptide or other molecule recognizing VLA-4, a protein expressed on the surface of certain leukocytes such as eosinophils.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: February 16, 1999
    Assignee: Biogen, Inc.
    Inventors: Roy R. Lobb, Linda C. Burkly